Hamill Laura (CIK 1751804) reported 6 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-08-07). Recent activity: Buy JAZZ (1,605 shares), Sell YMAB (5,825 shares), Sell YMAB (25,080 shares), Buy JAZZ (3,507 shares), Sell JAZZ (1,805 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-07 | Jazz Pharmaceuticals plc (JAZZ) | Director | Buy | 1,605 | $0 |
| 2025-09-19 | Y-mAbs Therapeutics, Inc. (YMAB) | Director | Sell | 5,825 | $50,095 |
| 2025-09-19 | Y-mAbs Therapeutics, Inc. (YMAB) | Director | Sell | 25,080 | $0 |
| 2025-08-11 | Jazz Pharmaceuticals plc (JAZZ) | Director | Buy | 3,507 | $0 |
| 2025-08-11 | Jazz Pharmaceuticals plc (JAZZ) | Director | Sell | 1,805 | $200,806 |
| 2025-07-02 | Y-mAbs Therapeutics, Inc. (YMAB) | Director | Buy | 25,080 | $0 |
Source: SEC Form 4 filings · as of 2026-08-07